1075 related articles for article (PubMed ID: 27803139)
1. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
2. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
[TBL] [Abstract][Full Text] [Related]
3. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.
Machado P; Landewé R; Braun J; Hermann KG; Baker D; van der Heijde D
Ann Rheum Dis; 2010 Aug; 69(8):1465-70. PubMed ID: 20498215
[TBL] [Abstract][Full Text] [Related]
4. Continuous Improvement of Physical Functioning in Ankylosing Spondylitis Patients by Tumor Necrosis Factor Inhibitors: Three-Year Followup and Predictors.
van Weely SF; Kneepkens EL; Nurmohamed MT; Dekker J; van der Horst-Bruinsma IE
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1522-9. PubMed ID: 26881893
[TBL] [Abstract][Full Text] [Related]
5. Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation?
Calvo-Gutierrez J; Garrido-Castro JL; Gil-Cabezas J; Gonzalez-Navas C; Ugalde PF; Carmona L; Collantes-Estevez E
Arthritis Care Res (Hoboken); 2015 Jan; 67(1):74-9. PubMed ID: 25049194
[TBL] [Abstract][Full Text] [Related]
6. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.
Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
Ann Rheum Dis; 2009 Jun; 68(6):863-7. PubMed ID: 18628283
[TBL] [Abstract][Full Text] [Related]
7. Effect of anti-tumor necrosis factor α treatment on radiographic progression in patient with ankylosing spondylitis: A systematic review and meta-analysis.
Zong HX; Xu SQ; Tong H; Wang XR; Pan MJ; Teng YZ
Mod Rheumatol; 2019 May; 29(3):503-509. PubMed ID: 30220240
[TBL] [Abstract][Full Text] [Related]
8. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
Maas F; Arends S; Brouwer E; Essers I; van der Veer E; Efde M; van Ooijen PMA; Wolf R; Veeger NJGM; Bootsma H; Wink FR; Spoorenberg A
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1011-1019. PubMed ID: 27696754
[TBL] [Abstract][Full Text] [Related]
9. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
[TBL] [Abstract][Full Text] [Related]
10. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.
Baraliakos X; Listing J; Rudwaleit M; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Oct; 64(10):1462-6. PubMed ID: 15778240
[TBL] [Abstract][Full Text] [Related]
11. Etanercept in the longterm treatment of patients with ankylosing spondylitis.
Dijkmans B; Emery P; Hakala M; Leirisalo-Repo M; Mola EM; Paolozzi L; Salvarani C; Sanmarti R; Sibilia J; Sieper J; Van Den Bosch F; van der Heijde D; van der Linden S; Wajdula J
J Rheumatol; 2009 Jun; 36(6):1256-64. PubMed ID: 19411393
[TBL] [Abstract][Full Text] [Related]
12. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.
Pedersen SJ; Weber U; Said-Nahal R; Sørensen IJ; Loft AG; Kollerup G; Juul L; Frandsen PB; Thamsborg G; Madsen OR; Møller J; Balding L; Jurik AG; Østergaard M
Scand J Rheumatol; 2019 May; 48(3):185-197. PubMed ID: 30422733
[TBL] [Abstract][Full Text] [Related]
13. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
14. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.
Haroon N; Inman RD; Learch TJ; Weisman MH; Lee M; Rahbar MH; Ward MM; Reveille JD; Gensler LS
Arthritis Rheum; 2013 Oct; 65(10):2645-54. PubMed ID: 23818109
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
van der Heijde D; Breban M; Halter D; DiVittorio G; Bratt J; Cantini F; Kary S; Pangan AL; Kupper H; Rathmann SS; Sieper J; Mease PJ
Rheumatology (Oxford); 2015 Jul; 54(7):1210-9. PubMed ID: 25541333
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs.
Perrotta FM; Addimanda O; Ramonda R; D'Angelo S; Lubrano E; Marchesoni A; Olivieri I; Punzi L; Salvarani C; Spadaro A
Reumatismo; 2014 Nov; 66(3):208-14. PubMed ID: 25376955
[TBL] [Abstract][Full Text] [Related]
17. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.
Baraliakos X; Listing J; Brandt J; Haibel H; Rudwaleit M; Sieper J; Braun J
Rheumatology (Oxford); 2007 Sep; 46(9):1450-3. PubMed ID: 17623745
[TBL] [Abstract][Full Text] [Related]
18. Performance of ultrasound to monitor Achilles enthesitis in patients with ankylosing spondylitis during TNF-a antagonist therapy.
Wang CH; Feng Y; Ren Z; Yang X; Jia JF; Rong MY; Li XY; Wu ZB
Clin Rheumatol; 2015 Jun; 34(6):1073-8. PubMed ID: 25896532
[TBL] [Abstract][Full Text] [Related]
19. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
van der Heijde D; Landewé R; Baraliakos X; Houben H; van Tubergen A; Williamson P; Xu W; Baker D; Goldstein N; Braun J;
Arthritis Rheum; 2008 Oct; 58(10):3063-70. PubMed ID: 18821688
[TBL] [Abstract][Full Text] [Related]
20. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
